Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1A | P35348 | 1/20 | 0.51 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.50 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.42 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 8/20 | 0.41 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16190294 | 1.00 | ADRA1A (0.51) | ADRA1APRMT1PLA2G2AMAPK1FOLH1 | |
| SCHEMBL16190319 | 1.00 | ADRA1A (0.51) | ADRA1APRMT1PLA2G2AMAPK1FOLH1 | |
| SCHEMBL16190295 | 1.00 | ADRA1A (0.51) | ADRA1APRMT1PLA2G2AMAPK1FOLH1 | |
| SCHEMBL16190317 | 1.00 | ADRA1A (0.51) | ADRA1APRMT1PLA2G2AMAPK1FOLH1 | |
| SCHEMBL16190320 | 1.00 | ADRA1A (0.51) | ADRA1APRMT1PLA2G2AMAPK1FOLH1 | |
| SCHEMBL16190292 | 1.00 | ADRA1A (0.51) | ADRA1APRMT1PLA2G2AMAPK1FOLH1 | |
| SCHEMBL16190298 | 1.00 | ADRA1A (0.51) | ADRA1APRMT1PLA2G2AMAPK1FOLH1 | |
| SCHEMBL16190305 | 0.87 | ADRA1A (0.55) | ADRA1APRMT1PLA2G2AMAPK1GSTK1 | |
| SCHEMBL16190350 | 0.87 | ADRA1A (0.55) | ADRA1APRMT1PLA2G2AMAPK1GSTK1 | |
| SCHEMBL19388102 | 0.87 | ADRA1A (0.55) | ADRA1APRMT1PLA2G2AMAPK1GSTK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9770398-B2 | pH-sensitive compound, use, composition and treatment process using same | L'OREAL (FR) | 2017-09-26 | — | — | US | disclosed |
| US-20140316006-A1 | PH-SENSITIVE COMPOUND, USE, COMPOSITION AND TREATMENT PROCESS USING SAME | L'OREAL (FR) | 2014-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140316006-A1 | PH-SENSITIVE COMPOUND, USE, COMPOSITION AND TREATMENT PROCESS USING SAME | KRT18, FH, DSP | ADRA1A 4754/4885PRMT1 4126/4885PLA2G2A 4324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.